Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4B | 2.3B | 1.3B | 1.5B |
Cost of revenue | 1.4B | 2.3B | 1.3B | 1.5B |
Gross profit | 21.4M | -2.9M | 30.8M | 97.0M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 37.8M | 17.9M | 16.9M | 34.7M |
Operating income | -26.1M | -30.6M | 4.1M | 52.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.4M | 1.5M | 1.1M | 4.5M |
Other income expense | — | — | — | — |
Pretax income | -25.5M | -15.2M | 3.3M | 48.5M |
Tax provision | -7.0M | -2.8M | -1.2M | 14.2M |
Net income | -18.5M | -12.4M | 4.4M | 34.3M |
Basic EPS | — | 0.0 | 0.0 | 0.1 |
Diluted EPS | — | 0.0 | 0.0 | 0.1 |
Basic average shares | — | 309.1M | 443.8M | 351.7M |
Diluted average shares | — | 309.1M | 443.8M | 351.7M |
EBITDA | -21.1M | -17.8M | 8.0M | 56.2M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |